Ocugen Inc (NASDAQ:OCGN) Stock Falls As FDA places Clinical Hold
The slide in the Ocugen Inc (NASDAQ:OCGN) stock continued on Tuesday as the selloff carried on and it ended the day with a decline of 4%. That took the cumulative decline in the stock over the course of the past week to as much as 14%. Trading Data On Tuesday, OCGN stock moved down 3.80% to $2.79 with 10.28 million shares, compared to its average volume of 12.08 million shares….